Trial Profile
Evaluation of Doxil as First-Line Therapy of Advanced or Recurrent Endometrial Carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2013
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Endometrial cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Sep 2005 New trial record.